Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection.
D000230:Adenocarcinoma / Q000175:diagnosis; D000368:Aged; D001761:Bleomycin; D001932:Brain Neoplasms / Q000175:diagnosis; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis; D002951:Citrates; D003037:Cobalt Radioisotopes; D003102:Colloids; D003110:Colonic Neoplasms / Q000175:diagnosis; D005260:Female; D005708:Gallium; D006801:Humans; D007204:Indium; D008113:Liver Neoplasms / Q000175:diagnosis; D008175:Lung Neoplasms / Q000175:diagnosis; D008297:Male; D008545:Melanoma / Q000175:diagnosis; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000175:diagnosis*; D011877:Radionuclide Imaging; D013455:Sulfur; D013667:Technetium
D002951:Citrates; D003037:Cobalt Radioisotopes; D003102:Colloids; D007204:Indium; D001761:Bleomycin; D013455:Sulfur; D013667:Technetium; D005708:Gallium